Merck & Co., Inc. Announced Acquisition of Prometheus Biosciences - Merck.com

Investors > Events & presentations > Events

Merck & Co., Inc. Announced Acquisition of Prometheus Biosciences

April 17, 2023 8:00 am EST

Dial in: (888) 769-8514 or (517) 308-9208

Access Code: 8206435

Webcast
Presentation
Prepared Remarks
Transcript

Contact Us

For investor inquiries

For questions about investor relations, please contact our team.

opt-in primary image

Sign up for email alerts